The tweet was deleted by the author.
But we saved everything 🙂.
Michael Taylor, co-founder and portfolio manager at Agora Trading, expressed concern about the recent MRNA study and its results. He believes payers will face significant difficulties related to the study.
View post on X Loading...
Taylor has recently commented on other financial developments in the technology sector. Earlier this month, he noted that Anthropic reduced its IPO valuation from $2 trillion to $1.5 trillion. He also compared over $800 billion in AI funding commitments tied to IPOs or high-yield debt to the scale of the 2008 U.S. housing bailout.